A

Aerovate Therapeutics
D

AVTE

2.65000
USD
-0.04
(-1.49%)
مغلق
حجم التداول
3,765
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
76,517,459
الأخبار

العنوان: Aerovate Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powderinhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.